跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
ZEPZELCA
Authorized
STANDARD
ZEPZELCA
JAZZ PHARMACEUTICALS IRELAND LIMITED
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b7a9f2140d32713a
Company
JAZZ PHARMACEUTICALS IRELAND LIMITED
Type
Standard
Approval Details
Approval Id
b7a9f2140d32713a
Drug Approval Canada Name
ZEPZELCA
Product Name
ZEPZELCA
Status
Marketed
Status Date
2021-12-06
Original Market Date
2021-12-06
Din
02520834
Drug Class
Human
Dosage Form
Powder
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01XX69 LURBINECTEDIN
Atc Name
l 01 xx 69
Aig Number
0163176001
Company Name
JAZZ PHARMACEUTICALS IRELAND LIMITED
Company Address
5th Floor, Waterloo Exchange, Waterloo Rd., Dublin, Dublin, Ireland, D04 E5W7
Company Detail Path
/organization/jazz-pharmaceuticals-ireland-limited
Company Information
Pharmaceutical Company Name
JAZZ PHARMACEUTICALS IRELAND LIMITED
Country Name
Ireland
City Name
dublin,country_ie
Address
5th Floor Waterloo Exchange
Active Ingredients
LURBINECTEDIN
4 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b7a9f2140d32713a
Type
Standard
Back to Health Canada Approvals